Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use

Mark S Scher1, John Alvin, Lisa Gaus

  • 1Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA.

Pediatric Neurology
|July 10, 2003
PubMed

Insights

Phenobarbital and phenytoin were studied for neonatal seizure cessation. Serial electroencephalographic monitoring revealed that even with reduced clinical seizures, electrographic seizures can persist, a phenomenon termed uncoupling.

Area of Science:

  • Neonatal neurology
  • Clinical pharmacology
  • Pediatric epilepsy

Background:

  • Neonatal seizures are a critical concern requiring effective treatment.
  • Phenobarbital and phenytoin are commonly used antiepileptic drugs (AEDs) for neonatal seizures.
  • Understanding treatment efficacy requires assessing both clinical and electrographic seizure activity.

Purpose of the Study:

  • To compare the efficacy of phenobarbital versus phenytoin in achieving seizure cessation in neonates.
  • To investigate the phenomenon of 'uncoupling' where electrographic seizures persist despite clinical seizure suppression.

Main Methods:

  • A prospective study involving 59 neonates with electrically-confirmed seizures.
  • Neonates were assigned to phenobarbital or phenytoin and monitored for 24 hours.
  • Clinical and electroencephalographic (EEG) seizure expressions were assessed before and after drug administration.

Main Results:

  • Twenty-four infants achieved complete seizure cessation with the first AED choice.
  • Of the 26 infants with persistent seizures, 15 (58%) exhibited uncoupling.
  • Uncoupling occurred similarly regardless of the AED used, prematurity, or gender.

Conclusions:

  • Serial EEG monitoring is crucial for evaluating AED efficacy in neonatal seizures.
  • The phenomenon of uncoupling highlights the need to monitor electrographic seizure activity beyond clinical observation.
  • Phenobarbital and phenytoin demonstrated similar efficacy profiles concerning uncoupling in this cohort.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types: